109451
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
中国稳定期慢性阻塞性肺疾病治疗决策：基于多变量离散选择模型的观察性横断面调查
Authors Cui J, Tang C, Li H, Zhou Y, Li S
Received 23 May 2025
Accepted for publication 26 September 2025
Published 29 October 2025 Volume 2025:20 Pages 3483—3494
DOI https://doi.org/10.2147/COPD.S537500
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Jill Ohar
Jiangyu Cui, Chunli Tang, Hongjia Li, Yumin Zhou, Shiyue Li
Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of China
Correspondence: Shiyue Li, First Affiliated Hospital of Guangzhou Medical University, No. 28 Qiaozhong Zhong Road, Liwan District, Guangzhou, Guangdong, People’s Republic of China, Tel +86-020-81567289, Email 49282811@qq.com
Purpose: To understand the current situation of respiratory and community physicians in China regarding the initial treatments for patients with chronic obstructive pulmonary disease (COPD).
Patients and Methods: A multivariate discrete choice model was applied to simulate patients with stable COPD, and an online questionnaire was randomly provided to respiratory physicians and community physicians. The questionnaire responses and medications prescribed to the simulated patients by the doctors in the different groups were analyzed and compared.
Results: (1) This study surveyed 109 doctors who made prescription decisions for 872 simulated COPD patients. (2) The results of the questionnaire revealed that the percentages of LAMA, LAMA/LABA and triple therapies that could be prescribed in community health care centers were 40.6%, 25%, and 34.4%, respectively. More than 60% of the physicians in the CHC and SH groups prescribed ICS/LABA as an initial regimen for maintenance therapy. (3) Triple therapy accounted for the highest proportion of prescriptions at 49%, followed by dual bronchodilator therapy (29.6%), whereas LAMA monotherapy represented the smallest share, with only 4.9% of prescriptions. Notably, ICS/LABA combination therapy represented a clinically relevant proportion of prescriptions (14.3%). A total of 58.9% of the 170 simulated COPD patients without asthma in the current study were prescribed triple therapy by their physicians. Approximately 60% of the COPD patients in Groups A and B were prescribed triple therapy as an initial treatment regimen, despite blood EOS counts of 100– 300 cells/μL in both groups.
Conclusion: Although most respiratory physicians follow guidelines for the choice of initial therapy for COPD, there are still irregularities in the use of triple therapy. A clinically relevant percentage of physicians, especially community physicians, selected ICS+LABA as the initial treatment choice. These practice irregularities should be the focus of future guidelines for promotion and education.
Keywords: COPD, treatment, cross-sectional survey, multivariate discrete choice modeling
Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of China
Correspondence: Shiyue Li, First Affiliated Hospital of Guangzhou Medical University, No. 28 Qiaozhong Zhong Road, Liwan District, Guangzhou, Guangdong, People’s Republic of China, Tel +86-020-81567289, Email 49282811@qq.com
Purpose: To understand the current situation of respiratory and community physicians in China regarding the initial treatments for patients with chronic obstructive pulmonary disease (COPD).
Patients and Methods: A multivariate discrete choice model was applied to simulate patients with stable COPD, and an online questionnaire was randomly provided to respiratory physicians and community physicians. The questionnaire responses and medications prescribed to the simulated patients by the doctors in the different groups were analyzed and compared.
Results: (1) This study surveyed 109 doctors who made prescription decisions for 872 simulated COPD patients. (2) The results of the questionnaire revealed that the percentages of LAMA, LAMA/LABA and triple therapies that could be prescribed in community health care centers were 40.6%, 25%, and 34.4%, respectively. More than 60% of the physicians in the CHC and SH groups prescribed ICS/LABA as an initial regimen for maintenance therapy. (3) Triple therapy accounted for the highest proportion of prescriptions at 49%, followed by dual bronchodilator therapy (29.6%), whereas LAMA monotherapy represented the smallest share, with only 4.9% of prescriptions. Notably, ICS/LABA combination therapy represented a clinically relevant proportion of prescriptions (14.3%). A total of 58.9% of the 170 simulated COPD patients without asthma in the current study were prescribed triple therapy by their physicians. Approximately 60% of the COPD patients in Groups A and B were prescribed triple therapy as an initial treatment regimen, despite blood EOS counts of 100– 300 cells/μL in both groups.
Conclusion: Although most respiratory physicians follow guidelines for the choice of initial therapy for COPD, there are still irregularities in the use of triple therapy. A clinically relevant percentage of physicians, especially community physicians, selected ICS+LABA as the initial treatment choice. These practice irregularities should be the focus of future guidelines for promotion and education.
Keywords: COPD, treatment, cross-sectional survey, multivariate discrete choice modeling